Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30years
Awards & highlights
Summary
This trial is testing a new way to manage Wilson's Disease, a rare genetic disorder that causes copper to build up in the body.
Eligible Conditions
- Wilson's Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 30years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The change of Unified Wilson's Disease Rating Scale (UWDRS)
Trial Design
4Treatment groups
Experimental Treatment
Group I: Unrelated healthy controlsExperimental Treatment1 Intervention
Group II: Relatives of Wilson's Disease patients or carriersExperimental Treatment1 Intervention
Group III: Patients with the genetic diagnosis of Wilson's DiseaseExperimental Treatment1 Intervention
Group IV: Asymptomatic Wilson's Disease carriersExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Wan-Jin ChenLead Sponsor
4 Previous Clinical Trials
5,402 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger